Cytosolic Sensing of Intracellular Staphylococcus aureus by Mast Cells Elicits a Type I IFN Response That Enhances Cell-Autonomous Immunity
- 1 April 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 208 (7) , 1675-1685
Abstract
Strategically located at mucosal sites, mast cells are instrumental in sensing invading pathogens and modulating the quality of the ensuing immune responses depending on the nature of the infecting microbe. It is believed that mast cells produce type I IFN (IFN-I) in response to viruses, but not to bacterial infections, because of the incapacity of bacterial pathogens to internalize within mast cells, where signaling cascades leading to IFN-I production are generated. However, we have previously reported that, in contrast with other bacterial pathogens, Staphylococcus aureus can internalize into mast cells and therefore could trigger a unique response. In this study, we have investigated the molecular cross-talk between internalized S. aureus and the human mast cells HMC-1 using a dual RNA sequencing approach. We found that a proportion of internalized S. aureus underwent profound transcriptional reprogramming within HMC-1 cells to adapt to the nutrients and stress encountered in the intracellular environment and remained viable. HMC-1 cells, in turn, recognized intracellular S. aureus via cGMP–AMP synthase–STING–TANK-binding kinase 1 signaling pathway, leading to the production of IFN-I. Bacterial internalization and viability were crucial for IFN-I induction because inhibition of S. aureus internalization or infection with heat-killed bacteria completely prevented the production of IFN-I by HMC-1 cells. Feeding back in an autocrine manner in S. aureus–harboring HMC-1 cells and in a paracrine manner in noninfected neighboring HMC-1 cells, IFN-I promoted a cell-autonomous antimicrobial state by inducing the transcription of IFN-I–stimulated genes. This study provides unprecedented evidence of the capacity of mast cells to produce IFN-I in response to a bacterial pathogen. Key Points Staphylococcus aureus can internalize and survive within the human mast cells. Mast cells produce type I IFN in response to intracellular S. aureus. Type I IFN enhances cell-autonomous immunity in human mast cells.Keywords
Funding Information
- Helmholtz Centre for Infection Research (0703/68674/5/2017)
- Interdisciplinary Centre for Clinical Researchers Würzburg (IZKF Z-6 to E.K.)
This publication has 60 references indexed in Scilit:
- Complete Genome Sequence of Staphylococcus aureus 6850, a Highly Cytotoxic and Clinically Virulent Methicillin-Sensitive Strain with Distant Relatedness to Prototype StrainsMicrobiology Resource Announcements, 2013
- STING-Dependent Recognition of Cyclic di-AMP Mediates Type I Interferon Responses during Chlamydia trachomatis InfectionmBio, 2013
- Sialic Acid Catabolism in Staphylococcus aureusJournal of Bacteriology, 2013
- BSRD: a repository for bacterial small regulatory RNANucleic Acids Research, 2012
- Mast cell-orchestrated immunity to pathogensNature Reviews Immunology, 2010
- Mast cells elicit proinflammatory but not type I interferon responses upon activation of TLRs by bacteriaProceedings of the National Academy of Sciences, 2010
- STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunityNature, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Human Mast Cell Activation byStaphylococcus aureus: Interleukin-8 and Tumor Necrosis Factor Alpha Release and the Role of Toll-Like Receptor 2 and CD48 MoleculesInfection and Immunity, 2008
- Interaction of the GraRS Two-Component System with the VraFG ABC Transporter To Support Vancomycin-Intermediate Resistance in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2007